Healthcare Market Access: Vietnam
The report provides in-depth information on:
- Country Landscape – This section covers information on the prevailing economic environment in the country and dwells on both macro and micro economic indicators. The demographic profile of the country highlights the growing importance of middle class and increasing access to internet. It also captures the political landscape along with the opportunities and challenges presented by the country.
- Healthcare infrastructure – Insightful review of the country’s healthcare system and health status with key health indicators are presented in this section. Moreover, healthcare expenditure and share of public and private sectors are prominently discussed in the section. The profiles of major hospitals and the number of healthcare personnel in the country are also comprehensively covered.
- Overview of Pharmaceutical Market – This section depicts the pharmaceutical market in terms of size, growth, product mix and key players operating in the country. A special emphasis has been laid on the key drivers and barriers impacting the pharmaceutical market of the country. Furthermore, the profiles of major diseases with high burden for the country have been covered.
- Market Access: This section dwells on the role and importance of various stakeholders in product commercialization process and gatekeepers holding the key to the access for pharmaceutical products. Various regulatory aspects crucial for approval and marketing of various categories of pharmaceutical products have been captured comprehensively. In addition, detailed analysis of pricing and reimbursement landscape along with the prescribing policies and influence, price build-up and trends and various drug lists impacting reimbursement is covered.
1. COUNTRY LANDSCAPE
1.1 Economic environment
1.2 Economic indicators
1.2.1 Gross domestic product
1.2.2 Gross national income
1.2.3 Inflation
1.2.4 Foreign exchange reserves
1.2.5 Current account balance
1.2.6 Government net debt
1.2.7 Exchange rate
1.2.8 Foreign direct investment
1.2.9 Trade balance
1.3 Demographics
1.3.1 Population
1.3.2 Growth of middle class
1.3.3 Education and literacy
1.3.4 Access to internet
1.3.5 Employment
1.4 Political structure and environment
1.4.1 Current government
1.5 Trade associations
1.5.1 Vietnam Pharmaceutical Companies Association
1.6 Opportunity and challenges
2 HEALTHCARE INFRASTRUCTURE
2.1 Healthcare system
2.2 Health status
2.2.1 Life expectancy
2.2.2 Mortality rate
2.3 Healthcare policy
2.4 Healthcare financing and expenditure
2.5 Pharmaceutical expenditure
2.6 Shares of the public and private sectors
2.7 Spending in pharmaceutical R&D
2.8 Health insurance
2.9 Hospital sector
2.9.1 Major hospital profiles
2.9.1.1 Bach Mai Hospital
2.9.1.2 Cho Ray Hospital
2.9.1.3 Hue Central Hospital (HCH)
2.9.1.4 Hanoi French Hospital (L’Hopital Francais de Hanoi)
2.9.1.5 Hospital C in Da Nang
2.9.1.6 Viet Duc Hospital (Vietnam - Germany Hospital)
2.9.1.7 Trieu An Hospital (TAH)
2.9.1.8 Hong Ngoc Hospital
2.10 Healthcare personnel
3 OVERVIEW OF PHARMACEUTICAL MARKET
3.1 Market overview
3.2 Industry structure
3.3 Market segments
3.4 Opportunities and challenges
3.5 Major players
3.6 Key products
3.7 Leading therapeutic segments
3.8 Supply chain
3.8.1 Distribution
3.8.2 Retail
3.9 Sales and marketing
3.10 FDI in pharmaceutical industry
3.11 Events
3.12 Major diseases
3.12.1 Stroke
3.12.2 Cancer
3.12.3 Road traffic accidents
3.12.4 Tuberculosis
3.12.5 Diabetes mellitus
3.12.6 HIV/AIDS
4 MARKET ACCESS
4.1 Stakeholder landscape
4.2 Regulatory landscape
4.2.1 Regulatory agencies
4.2.2 Market authorization for pharmaceutical products
4.2.3 Clinical trial regulations
4.2.4 Licensing process for pharmaceutical manufacturing
4.2.5 Licensing process for pharmaceutical imports
4.2.6 Post-marketing regulations
4.2.7 Advertising
4.2.8 Labeling and packaging
4.2.9 Intellectual property rights
4.3 Pricing
4.3.1 Pricing system
4.3.2 Pricing policy
4.3.3 Price trends
4.3.4 Discounts and margins
4.4 Reimbursement landscape
4.4.1 Reimbursement process
4.4.2 Insurance providers
4.4.3 Co-payments
4.5 Prescribing and dispensing
4.5.1 Prescribing guidelines
4.5.2 Prescribing influences
4.5.3 Dispensing
4.6 Essential drug list
4.7 Reimbursement drug list
4.8 Drug procurement
4.9 Hospital formulary
5 APPENDIX
5.1 Glossary
5.2 Bibliography
5.3 Methodology
5.3.1 Secondary research
5.3.2 Primary research
5.3.3 Data validation
5.4 Disclaimer
5.5 Contact us
1.1 Economic environment
1.2 Economic indicators
1.2.1 Gross domestic product
1.2.2 Gross national income
1.2.3 Inflation
1.2.4 Foreign exchange reserves
1.2.5 Current account balance
1.2.6 Government net debt
1.2.7 Exchange rate
1.2.8 Foreign direct investment
1.2.9 Trade balance
1.3 Demographics
1.3.1 Population
1.3.2 Growth of middle class
1.3.3 Education and literacy
1.3.4 Access to internet
1.3.5 Employment
1.4 Political structure and environment
1.4.1 Current government
1.5 Trade associations
1.5.1 Vietnam Pharmaceutical Companies Association
1.6 Opportunity and challenges
2 HEALTHCARE INFRASTRUCTURE
2.1 Healthcare system
2.2 Health status
2.2.1 Life expectancy
2.2.2 Mortality rate
2.3 Healthcare policy
2.4 Healthcare financing and expenditure
2.5 Pharmaceutical expenditure
2.6 Shares of the public and private sectors
2.7 Spending in pharmaceutical R&D
2.8 Health insurance
2.9 Hospital sector
2.9.1 Major hospital profiles
2.9.1.1 Bach Mai Hospital
2.9.1.2 Cho Ray Hospital
2.9.1.3 Hue Central Hospital (HCH)
2.9.1.4 Hanoi French Hospital (L’Hopital Francais de Hanoi)
2.9.1.5 Hospital C in Da Nang
2.9.1.6 Viet Duc Hospital (Vietnam - Germany Hospital)
2.9.1.7 Trieu An Hospital (TAH)
2.9.1.8 Hong Ngoc Hospital
2.10 Healthcare personnel
3 OVERVIEW OF PHARMACEUTICAL MARKET
3.1 Market overview
3.2 Industry structure
3.3 Market segments
3.4 Opportunities and challenges
3.5 Major players
3.6 Key products
3.7 Leading therapeutic segments
3.8 Supply chain
3.8.1 Distribution
3.8.2 Retail
3.9 Sales and marketing
3.10 FDI in pharmaceutical industry
3.11 Events
3.12 Major diseases
3.12.1 Stroke
3.12.2 Cancer
3.12.3 Road traffic accidents
3.12.4 Tuberculosis
3.12.5 Diabetes mellitus
3.12.6 HIV/AIDS
4 MARKET ACCESS
4.1 Stakeholder landscape
4.2 Regulatory landscape
4.2.1 Regulatory agencies
4.2.2 Market authorization for pharmaceutical products
4.2.3 Clinical trial regulations
4.2.4 Licensing process for pharmaceutical manufacturing
4.2.5 Licensing process for pharmaceutical imports
4.2.6 Post-marketing regulations
4.2.7 Advertising
4.2.8 Labeling and packaging
4.2.9 Intellectual property rights
4.3 Pricing
4.3.1 Pricing system
4.3.2 Pricing policy
4.3.3 Price trends
4.3.4 Discounts and margins
4.4 Reimbursement landscape
4.4.1 Reimbursement process
4.4.2 Insurance providers
4.4.3 Co-payments
4.5 Prescribing and dispensing
4.5.1 Prescribing guidelines
4.5.2 Prescribing influences
4.5.3 Dispensing
4.6 Essential drug list
4.7 Reimbursement drug list
4.8 Drug procurement
4.9 Hospital formulary
5 APPENDIX
5.1 Glossary
5.2 Bibliography
5.3 Methodology
5.3.1 Secondary research
5.3.2 Primary research
5.3.3 Data validation
5.4 Disclaimer
5.5 Contact us
